Population
Rat vascular smooth muscle cells (VSMCs)
Comparison
MAPK signaling inhibition using PD 98059 or… vs Control ODN-transfected VSMCs or uninhibited Ang…
Design
Preclinical
Authors
Loading...
Supports MAPK inhibition to curb Ang II-driven VSMC growth; leaves open translation to human vascular disease.
MAPK is a critical regulatory factor for Ang II-mediated migration and growth in vascular smooth muscle cells, with DNA synthesis showing stronger MAPK dependence than migration or c-fos induction.
Xi et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: